ARRY-382 in Combination with Pembrolizumab in Patients with Advanced Solid Tumors: Results from a Phase 1b/2 Study
- Melissa Johnson
- , Arkadiusz Z. Dudek
- , Ammar Sukari
- , Justin Call
- , Paul R. Kunk
- , Karl Lewis
- , Justin F. Gainor
- , John Sarantopoulos
- , Patrice Lee
- , Adele Golden
- , Allison Harney
- , S. Michael Rothenberg
- , Yuanyuan Zhang
- , Jonathan W. Goldman
Research output: Contribution to journal › Article › peer-review
58
Link opens in a new tab
Scopus
citations